Cystic Fibrosis Therapeutics and Sleep-Breathing Disorders
Andrew Braun, MD, MHS, is a clinician and researcher whose interests include cystic fibrosis therapeutics, sleep-related breathing disorders, metabolic consequences of advanced lung disease, and lung transplantation.
Cystic Fibrosis Clinical Trials
Dr. Braun leads patient-centered clinical research into cystic fibrosis (CF) therapeutics for adults and pediatric patients.
The University of Wisconsin–Madison’s Cystic Fibrosis Center has made notable contributions to CF research, include the development of the Cystic Fibrosis Newborn Screening Program that is used around the world. The Center is part of the Cystic Fibrosis Foundation Therapeutics Development Network.
Visit the Cystic Fibrosis Clinical Trials website.